Detalles de la búsqueda
1.
Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
Clin Infect Dis
; 78(4): 1056-1064, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38051664
2.
Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
MMWR Morb Mortal Wkly Rep
; 73(8): 168-174, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38421935
3.
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
J Infect Dis
; 228(3): 235-244, 2023 08 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36883903
4.
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
Clin Infect Dis
; 77(4): 547-557, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37255285
5.
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023.
MMWR Morb Mortal Wkly Rep
; 72(17): 463-468, 2023 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37104244
6.
Disease Severity of Respiratory Syncytial Virus Compared with COVID-19 and Influenza Among Hospitalized Adults Aged ≥60 Years - IVY Network, 20 U.S. States, February 2022-May 2023.
MMWR Morb Mortal Wkly Rep
; 72(40): 1083-1088, 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37796753
7.
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years - IVY Network, 18 States, September 8-November 30, 2022.
MMWR Morb Mortal Wkly Rep
; 71(5152): 1625-1630, 2022 Dec 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36580424
8.
Effectiveness of Monovalent mRNA Vaccines Against COVID-19-Associated Hospitalization Among Immunocompetent Adults During BA.1/BA.2 and BA.4/BA.5 Predominant Periods of SARS-CoV-2 Omicron Variant in the United States - IVY Network, 18 States, December 26, 2021-August 31, 2022.
MMWR Morb Mortal Wkly Rep
; 71(42): 1327-1334, 2022 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36264830
9.
A Comparison of Less Invasive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Diagnostic Specimens in Nursing Home Residents-Arkansas, June-August 2020.
Clin Infect Dis
; 73(Suppl 1): S58-S64, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909063
10.
Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalization - Five Veterans Affairs Medical Centers, United States, February 1-August 6, 2021.
MMWR Morb Mortal Wkly Rep
; 70(37): 1294-1299, 2021 Sep 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-34529636
11.
Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
MMWR Morb Mortal Wkly Rep
; 70(49): 1700-1705, 2021 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34882654
12.
Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019.
MMWR Morb Mortal Wkly Rep
; 69(12): 329-334, 2020 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32214084
13.
Assessing the impact of antiretroviral therapy on tuberculosis notification rates among people with HIV: a descriptive analysis of 23 countries in sub-Saharan Africa, 2010-2015.
BMC Infect Dis
; 18(1): 481, 2018 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30257667
14.
Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.
Emerg Infect Dis
; 23(3): 487-490, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-27869604
15.
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.
Lancet Microbe
; 5(3): e235-e246, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38286131
16.
Antigenic Characterization of Circulating and Emerging SARS-CoV-2 Variants in the U.S. throughout the Delta to Omicron Waves.
Vaccines (Basel)
; 12(5)2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38793756
17.
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
JAMA Netw Open
; 7(4): e244954, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38573635
18.
Fungal Pathogens as Causes of Acute Respiratory Illness in Hospitalized Veterans: Frequency of Fungal Positive Test Results Using Rapid Immunodiagnostic Assays.
J Fungi (Basel)
; 9(4)2023 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37108910
19.
SARS-CoV-2 shedding and evolution in immunocompromised hosts during the Omicron period: a multicenter prospective analysis.
medRxiv
; 2023 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37662226
20.
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022.
Open Forum Infect Dis
; 10(1): ofac698, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36695662